Therefore, it was shown that the addition of TNFα can modulate the activity of doxorubicin and lead to a significant increase in its content in the tumor tissue in models of sarcoma, as well as the effective regression of fibrosarcoma BN175 and osteosarcoma ROS-1 [267]. This evidence concerns the gene TNF and neoplasm.